Suppr超能文献

相似文献

6
[Surgical treatment of primary liver cancer:a report of 10 966 cases].
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):6-17. doi: 10.3760/cma.j.cn112139-20201110-00791.
7
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
10
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Ann Surg. 2003 Oct;238(4):508-18; discussion 518-9. doi: 10.1097/01.sla.0000090449.87109.44.

引用本文的文献

2
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma.
Ther Adv Med Oncol. 2025 Jul 24;17:17588359251357719. doi: 10.1177/17588359251357719. eCollection 2025.
5
Hepatocellular carcinoma recurrence: Predictors and management.
Liver Res. 2023 Nov 19;7(4):321-332. doi: 10.1016/j.livres.2023.11.004. eCollection 2023 Dec.
7
Risk of early hepatocellular carcinoma recurrence following liver resection: arbitrary specification or possible target to improve outcome?
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):745-748. doi: 10.21037/hbsn-24-202. Epub 2024 Jul 12.
8
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome.
JHEP Rep. 2024 Apr 24;6(7):101075. doi: 10.1016/j.jhepr.2024.101075. eCollection 2024 Jul.
9
PHLDA2 reshapes the immune microenvironment and induces drug resistance in hepatocellular carcinoma.
Oncol Res. 2024 May 23;32(6):1063-1078. doi: 10.32604/or.2024.047078. eCollection 2024.

本文引用的文献

1
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2021 May 1;19(5):541-565. doi: 10.6004/jnccn.2021.0022.
2
Risk factors for hepatocellular carcinoma.
Clin Liver Dis (Hoboken). 2013 Jan 23;1(6):180-182. doi: 10.1002/cld.111. eCollection 2012 Dec.
4
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
Gastroenterology. 2019 Jul;157(1):54-64. doi: 10.1053/j.gastro.2019.02.049. Epub 2019 Apr 12.
5
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Clin Mol Hepatol. 2019 Sep;25(3):264-269. doi: 10.3350/cmh.2019.1001. Epub 2019 Mar 4.
7
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
J Hepatol. 2018 Dec;69(6):1284-1293. doi: 10.1016/j.jhep.2018.08.027. Epub 2018 Sep 18.
8
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
9
Current status and strategies for hepatitis B control in Korea.
Clin Mol Hepatol. 2017 Sep;23(3):205-211. doi: 10.3350/cmh.2017.0104. Epub 2017 Sep 19.
10
AASLD guidelines for the treatment of hepatocellular carcinoma.
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验